This web site is supported by independent educational grants from Regeneron Pharmaceuticals, Inc, Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.
Sequential Continuing Education Programs for Managed Care and Payer Professionals Increase Knowledge of Breakthrough Therapies for the Management of EoE Treatments